Specifically, we observed an increased CD8+ to Treg cell ratio, heightened effector functions of CD8+ TILs, and the presence of SFB-3340-specific CD4+ T cells with pro-inflammatory properties in the tumor microenvironment. This evidence concerns the gene CD4 and neoplasm.